September 11 @ 11:00 am - September 13 @ 2:00 pm
Pharmaceutical Science in a Changing World
Reflecting the needs for sustainability and diversity in addressing the health of globally connected populations
Please view the latest programme for PharmSci, which will be updated as speakers announced
We are pleased to announce this year’s science chair is Professor Cameron Alexander
Cameron is Professor of Polymer Therapeutics, a Royal Society Wolfson Research Merit Fellow, an EPSRC Impact Fellow, and Head of the Division of Molecular Therapeutics and Formulation at the School of Pharmacy, University of Nottingham, UK.
He received degrees (BSc and PhD) in Chemistry from the University of Durham, UK and carried out post-doctoral research at the Melville Laboratory for Polymer Synthesis, University of Cambridge. He is a Fellow of the Royal Society of Chemistry and the Higher Education Academy, Chair of the Royal Society of Chemistry Macro Group UK, Chair of the EPSRC Strategic Advisory Team for Physical Sciences and a recent (2009-2014) EPSRC Leadership Fellow. Prof Alexander has published ~ 200 refereed articles in areas ranging from drug delivery and regenerative medicine to synthetic biology, receiving nearly 9000 citations to date. From 2006-2016, Cameron led the EPSRC Centre for Doctoral Training in Advanced Therapeutics and Nanomedicines at Nottingham and University College London with leading pharmaceutical industry partners. He received the Royal Society of Chemistry Macro Group Medal 2014 for contributions to polymer science.
He has been fortunate to work with scientists from more than 20 countries in his research group and is proud to serve the Academy of Pharmaceutical Sciences in the UKPharmSci conference
Contact details: School of Pharmacy, University of Nottingham Boots Science Building, University of Nottingham, Nottingham NG7 2RD UK.
Tel: +44 (0) 115 846 7678; Fax +44 (0)115 951 5102; Cameron.firstname.lastname@example.org
Dr Bruce Alexander, Principal Lecturer in Physical Chemistry, University of Greenwich
Professor Gavin Andrews-Queens University of Belfast.
Dr Michael Devlin, researcher, University of Strathclyde
Juan Domínguez Robles, School of Pharmacy, Queen’s University Belfast.
Professor Dennis Douroumis, University of Greenwich
Taherali Farhan, UCL School of Pharmacy
Sarah Goulding, Innovate UK Knowledge transfer Network (KTN)
Dr Andreea Iftimia-Manders- Enabling Programmes,UK Research and Innovation
Majella Lane, Senior Lecturer Pharmaceutics, University College London
Laura Mason, Upperton Pharma Solutions (UKICRS Treasurer)
Emma McAlister, Research Fellow, Queen’s University Belfast
Mark McAllister-Chair of APS,Pfizer
Professor Helen Osborn, Professor of Biomedicinal Chemistry, University of Reading
Yvonne Perrie, Strathclyde Institute of Pharmacy and Biomedical Sciences
Dr Sheng Qi, University of East Anglia.
Dr Allan Jordan, Director of Oncology Drug Discovery, Sygnature Discovery.
Professor Andrew Lewis, VP R&D, Biocompatibles UK Ltd
Dr Steven Ross, University of Greenwich.
David Scurr, University of Nottingham
Prof Martin Snowden, University of Greenwich
Silvia Sonzini, Senior Scientist, AstraZeneca
David Streather, Astra Zeneca
Professor Laura Waters, University of Huddersfield
Dr Bruce Alexander-University of Greenwich
Prof Abdul Basit-UCL
Dr Asma Buanz,UCL School of Pharmacy
Dr Fungayi Chidothe, Head of Strategy and Planning,Catapult
Neil Dawson, Pfizer
Andi Dian Permana, PhD Student, School of Pharmacy, Queens University Belfast
Dr Alexander Edwards, Associate Professor, University of Reading
Professor Dr Thomas Efferth, Editor-in- Chief, Phytomedicine Chair, Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry Johannes Gutenberg University
Professor Rachel Elliott, Professor In Health Economics, University of Manchester.
Dr Enrico Ferrari, Senior Lecturer, University of Lincoln
Dr Mark Frigerio, Ph.D Director, Chemistry UK, Abzena
Mr Jean Philippe Ganay, Pfizer
Professor Julie Hawkins, Professor of Plant Systematics and Evolution, School of Biological Sciences, University of Reading
Elliott Higgin, Postgraduate Research Student, King’s College London
Professor Fergal O’Brien, Royal College of Surgeons, Belfast.
David Jones, Pro-Vice-Chancellor for Education and Students at Queen’s University Belfast
Dr Yaroslav Khimyak- University of East Anglia
Dr Kristof Kimpe- Formulate me tinder
Professor Twan Lammers, Head of Department Nanomedicine and Theranostics, RWTH Aachen University
Dr Nathalie Lavignac, Lecturer, Medway School of Pharmacy
Az Alddien Natfji, PhD Student, School of Pharmacy, University of Reading
Angela Osborne, Managing Director, ATMP Manufacturing Community.
David Parmley- Centre for Process Innovation.
Asha Kumari Patel, Lecturer in Cell & Gene Therapy, Imperial College London
Yvonne Pendry, University of Greenwich
Jean Philippe Panay-Pfizer
Dr Kendal Pitt-Senior Technical Director, Pharma Supply Chain, GSK
Jukka Rantanen, professor of pharmaceutical technology and engineering at the Department of Pharmacy,University of Copenhagen
Professor Clive Roberts, Professor of Pharmaceutical Nanotechnology, Head of School of Pharmacy, University of Nottingham
Dr Bruno Sil dos Santos, Lecturer in Pharmaceutical Science and Pharmacology, School of Human Sciences, London Metropolitan University
Dr Hélder A. Santos, Associate Professor, University of Helsinki
Dr Floriane Séquier, Team Leader, Global Product Development, AstraZeneca
Professor Robin Shattock- Imperial College London.
Dr Ashraf Ismail Mcgill, University of Greenwich
Sarah J Trenfield, UCL School of Pharmacy
Dr Maria J. Vicent, PhD, Polymer Therapeutics Lab, Centro de Investigación príncipe Felipe
Dr Zoe Waller, University of East Anglia
Dr Keng Wooi Ng, Lecturer, Newcastle University
Vipul Yadav, Director of Research, Intract Pharma Ltd
Twan Lammers obtained a DSc degree in Radiation Oncology from Heidelberg University in 2008 and a PhD degree in Pharmaceutics from Utrecht University in 2009. In the same year, he started the Nanomedicine and Theranostics group at RWTH Aachen University Clinic. In 2014, he was promoted to full professor of medicine at RWTH Aachen. He has published over 150 research articles and reviews, and has received several scholarships and award. He is associate editor for Europe for the Journal of Controlled Release. His primary research interests include drug targeting to tumors, image-guided drug delivery and tumor-targeted combination therapies.
Nanomedicines are 1-100(0) nm-sized carrier materials designed to improve the biodistribution and the target site accumulation of systemically administered (chemo-) therapeutic drugs. By delivering drug molecules more efficiently to pathological sites, and by preventing them from accumulating in healthy tissues, nanomedicines are able to improve the balance between efficacy and toxicity. Nanomedicines rely on the Enhanced Permeability and Retention (EPR) effect for efficient target site accumulation, which is notoriously known to be highly variable, both in animal models and in patients. To overcome this high heterogeneity in EPR, and to improve the (pre-) clinical performance of cancer nanomedicines, we are working on systems and strategies to modulate and monitor tumor-targeted drug delivery. In the present lecture, several “smart” strategies will be highlighted, including pharmacological and physical modulation of tumor blood vessels and the microenvironment, and theranostic concepts for individualized and improved nanomedicine treatment.
The deadline for abstract submissions has now passed for review for a podium present.
Currently opportunities are available for late abstracts submissions are invited for consideration for posters only.
Please contact Valerie Bassigny (Conference management company for PharmSci) at Valerie.Bassigny@profileproductions.co.uk
This is one of the most exciting parts of the conference as it represents the presentation of the very latest pharmaceutical science research.
Abstracts on any aspect of the Pharmaceutical Sciences are welcomed and those with a particular emphasis on the theme of this year’s Conference, “Pharmaceutical Science in a Changing World” are particularly appreciated.
Details of the various subject categories, an abstract template and details of the entry process can be found here
Please ensure abstracts are submitted online and comply with the Abstract Submission Template.
There will be prizes awarded for winning posters on each day of the Conference and authors of abstracts of particular interest will be invited to give podium presentations (10 minutes) which is part of the main sessions within the conference. This is an excellent chance to get your science recognised at the UK’s premier Pharmaceutical Science Conference.
The APS received an exceptional pool of nominations this year, and are pleased to announce that
Professor Clive Roberts, Professor of Pharmaceutical Nanotechnology, Head of School of Pharmacy, University of Nottingham will deliver the APS plenary lecture this year.
Clive will deliver a lecture on
“The potential of 3D printing in the development and manufacture of medicines and its impact upon Pharmacy”
Clive has built an outstanding research profile that covers the application of novel analytical and formulation strategies to develop new medicines and biomedical devices. In particular, Clive is internationally known for his accomplishments in additive manufacturing (i.e. 3D printing), with the first example worldwide of ink jetting for drug formulations being published in 2011 (Scoutaris et al, J Control Release 156 (2), 179-185). Clive’s group and collaborations in 3D printing have addressed fundamental scientific issues needed to apply this technology for the printing of solid dosage forms. Much of this seminal work is now being funded by the EPSRC, AZ and GSK and the applications of this work are now being exhibited to the wider public (e.g. London Science Museum and Manchester Industrial Science Museum). Clive is also well known as an inspiring and engaging speaker at all levels, from schools visits through to the most prestigious international conferences (APS and CRS)
The APS plenary lecture award is sponsored by AstraZeneca and is awarded to nominated members of APS who have made an outstanding scientific contribution in their work and are ambassadors of international repute.
“I am delighted to have won the Emerging Scientist Award and will present my work entitled ‘Nano-assassins for pancreatic cancer therapy’ at this years PharmSci conference in University of Greenwich. “
Dr Clare Hoskins completed her PhD in Pharmaceutics at Robert Gordon University in Aberdeen under Dr Woei Ping Cheng and Professor Paul Kong Thoo Lin. In her PhD studies Clare developed novel comb shaped polymers for drug solubilisation. Following her PhD she was appointed as a postdoctoral researcher at the Institute of Medical Science and Technology (IMSaT), University of Dundee under the guidance of Professor Sir Alfred Cuschieri and Dr Lijun Wang specialising in the use of nanoparticles for regenerative medicine. In 2011 Clare was appointed as Lecturer in Pharmaceutics at Keele University with subsequent promotion to Senior Lecturer in 2016. The main focus of her work is in the development of nanoparticle based image guided and stimuli-responsive drug delivery systems. Dr Hoskins has over ten years of experience in nanomedicine development and has published forty peer-reviewed papers including those in top journals including Journal of Controlled Release and Nanoscale. Dr Hoskins has supervised or is supervising 10 PhD students and more than twenty Masters students. Within the research Institute for Science & Technology in Medicine (ISTM) Dr Hoskins leads Keele Nanopharmaceutics, a vibrant research group whose cutting-edge work in nanomedicine is challenging traditional approaches and pushing past current boundaries in cancer diagnosis and treatment. Dr Hoskins has been supported by Wellcome Trust, Newton-Bhabha & British Council, EPSRC, BBSRC, and the Iraqi Ministry of Higher Education and Scientific Research (MOHESR). Dr Hoskins is the Elected Secretary to the Royal Society of Chemistry, Chemical Nanosciences and Nanotechnology Network. She sits on the British Council Grant Review Panel for Newton Grants.
Sponsorship and Exhibiting-take a look at all the opportunities in our brochure
The conference includes a large pharmaceutical sciences exhibition to highlight big pharma companies, small and medium size enterprises (SMEs), contract research organisations (CROs) and technology suppliers.
This will be held in the Queen Mary Undercroft, so exhibitors will be situated where all refreshments are taken, with many opportunities during the conference for delegates to visit your table and discuss your company and services.
Table top (approx. 1.75m x 0.8m)
One full delegate Conference Pass
Company name and hyperlink on the Exhibition’ page
Cost of package £1000
One additional exhibitor only pass for the full conference can also be purchased for an additional colleague in your company for £250.
Additional Opportunity this year…….
For an additional fee exhibitors can have a 10-minute slot on the first day of the conference to present their company and technology allowing 5 minutes for questions. These are limited slots and will need to be booked. For our loyal supporters who have exhibited before these can be purchased at a 50 % reduction of £250.
If you have any questions, please contact
Profile Production (Managing Conference for APS)
Tel +44 (0)20 3725 5840
You can present your brand, company and products to our delegates, meet potential clients and new employees face to face. Use the exhibition space to demonstrate your services and products to over 400 potential partners and customers. The PharmSci Conference 2019 gives you the opportunity to connect with pharmaceutical industry, university research groups UK and globally, professionals and influential experts, and also to connect with future employees from the talented research students.
If you have any questions, please contact
Valerie BassignyConference DirectorProfile Production (Managing Conference for APS)
Tel +44 (0)20 3725 5840
Social Events-Opportunity to dine in the finest dinning hall in Europe-Painted Hall
This will take place on the first day and gives an ideal opportunity for delegates, speakers, exhibitors to socialise in the setting of the Queen Anne Courtyard. Drinks and food will be served. This is included in the registration cost for the delegate fees on the Wednesday.
Conference Black-Tie Dinner – Thursday 12th September 2019
This will take place in the The Painted Hall which is a striking baroque space designed by Sir Christopher Wren and Nicholas Hawksmoor, and often described as the “finest dining hall in Europe”. It features spectacular wall and ceiling decoration by Sir James Thornhill, who lavished 19 years on this, his masterwork. It has recently been closed for renovation since 2016, so gives the unique opportunity to see the works undertaken.
The black-tie dinner includes the Academy Awards Ceremony where the academy present awards to recognise the contribution of colleagues in the field.
PharmSci 2019 Black Tie Dinner is a prestige event attended by many of the key note speakers, board and advisory board of the Academy.
Book early for a saving on the cost of the ticket.
First 100 delegates £65(ex vat)-saving of approx 20%
First 20 students £45 (ex vat)-saving of approx 40 %
This is a great networking that we would like to open up to colleagues that can not attend the conference
External APS member external folk- £90 (ex vat)
External folk (not registered at the conference) and partners £100 (ex vat)
Accommodation and Venue
Located in the heart of Greenwich and overlooking the River Thames. Getting There.
The Greenwich Campus is on a World Heritage Site on the banks of the River Thames. The university’s largest campus is centred on three baroque buildings designed by Sir Christopher Wren at the end of the 17th century. The Independent newspaper described it as “more breathtaking than the Versailles of Louis XIV”. Read More.
Greenwich is a popular area in East London and accommodation can be found nearby in numerous hotels.
Delegates are able to book fully inclusive places at the conference, to include accommodation at the Travelodge in Greenwich or rooms within the University of Greenwich.
Travelodge London Greenwich
Double room for single or double occupancy, price doesn’t change.
11/09/2019- Double room £99-111
University of Greenwich
Single room only-can be booked for 10,11 & 12 September 2019-£50/night
All rooms are ensuite and are set out in a flat formation, each room contains the standard study-bedroom fittings (bed, bedside table, desk, chair, wardrobe, pinboard. Towels and shower gel are provided.
The address of the halls is:
Daniel Defoe Halls, University of Greenwich,10 Lovibond Lane, London SE10 9FY (located near the corner of Waller Way and Greenwich High Road).
|Members||1 day (Wed & Social)||2 days (Thus & Fri)||3 days (Wed & Social, Thurs & Fri)|
The social networking event on Wednesday 11th September is include in the delegate rate for that day.
This will take place on the first day and gives an ideal opportunity for delegates, speakers, exhibitors to socialise in the setting of the Queen Anne Courtyard. Drinks and food will be served.
The Conference Black-Tie Dinner is on the Thursday 12th September 2019 and will take place in the The Painted Hall. This can be booked separately when you register.
All prices specified in the price list are given exclusive of VAT.
Black Tie Dinner – Red Carpet Sponsor